. .: "targeted cgrp small molecule antagonists for acute migraine therapy.".understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study.. or water. symptoms include fatigue, low appetite, stomach pain, nausea, and jaundice..